BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 33723748)

  • 1. A narrative review of platelet-rich plasma (PRP) in reproductive medicine.
    Sharara FI; Lelea LL; Rahman S; Klebanoff JS; Moawad GN
    J Assist Reprod Genet; 2021 May; 38(5):1003-1012. PubMed ID: 33723748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.
    Vahabi Dastjerdi M; Sheibani S; Taheri M; Hezarcheshmeh FK; Jahangirian J; Jazayeri M; Hosseinirad H; Doohandeh T; Valizadeh R
    Arch Gynecol Obstet; 2024 Jun; 309(6):2323-2338. PubMed ID: 38589612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study.
    Melo P; Navarro C; Jones C; Coward K; Coleman L
    J Assist Reprod Genet; 2020 Apr; 37(4):855-863. PubMed ID: 32030554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis.
    Éliás M; Kónya M; Kekk Z; Turan C; das Virgens IPA; Tóth R; Keszthelyi M; Hegyi P; Várbíró S; Sipos M
    J Ovarian Res; 2024 May; 17(1):104. PubMed ID: 38760869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency.
    Cakiroglu Y; Saltik A; Yuceturk A; Karaosmanoglu O; Kopuk SY; Scott RT; Tiras B; Seli E
    Aging (Albany NY); 2020 Jun; 12(11):10211-10222. PubMed ID: 32507764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-ovarian infusion of autologous platelet-rich plasma in women with poor ovarian reserve: A before and after study.
    Hosseinisadat R; Farsi Nejad A; Mohammadi F
    Eur J Obstet Gynecol Reprod Biol; 2023 Jan; 280():60-63. PubMed ID: 36403398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma.
    Sills ES; Rickers NS; Li X; Palermo GD
    Gynecol Endocrinol; 2018 Sep; 34(9):756-760. PubMed ID: 29486615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis.
    Li X; Liu H; Lin G; Xu L
    Front Endocrinol (Lausanne); 2023; 14():1292168. PubMed ID: 38155954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.
    Aflatoonian A; Lotfi M; Saeed L; Tabibnejad N
    Reprod Sci; 2021 Jul; 28(7):2050-2059. PubMed ID: 33683669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP).
    Cakiroglu Y; Yuceturk A; Karaosmanoglu O; Kopuk SY; Korun ZEU; Herlihy N; Scott RT; Tiras B; Seli E
    Aging (Albany NY); 2022 Mar; 14(6):2513-2523. PubMed ID: 35320118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian response to intraovarian platelet-rich plasma (PRP) administration: hypotheses and potential mechanisms of action.
    Seckin S; Ramadan H; Mouanness M; Kohansieh M; Merhi Z
    J Assist Reprod Genet; 2022 Jan; 39(1):37-61. PubMed ID: 35175511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved
    Coksuer H; Akdemir Y; Ulas Barut M
    Gynecol Endocrinol; 2019 Sep; 35(9):815-818. PubMed ID: 30966843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: clinical and molecular aspects.
    Hajipour H; Farzadi L; Latifi Z; Keyhanvar N; Navali N; Fattahi A; Nouri M; Dittrich R
    Syst Biol Reprod Med; 2021 Jun; 67(3):177-188. PubMed ID: 33632047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of platelet rich plasma on women with poor ovarian response: a systematic review and meta-analysis.
    Wu L; Su F; Luo P; Dong Q; Ma M; Ye G
    Platelets; 2024 Dec; 35(1):2292612. PubMed ID: 38214306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating refractory thin endometrium through a novel way of activation and administration of Platelet-rich plasma in sexually active women: An interventional prospective cohort clinical study.
    Abbassi R; Haddad S; Haneyah F; Nakawa W; Murad MS; Issa AM; Alkheder A; Azar A; Dakhalalah Bani Hani M; Abbassi H
    Medicine (Baltimore); 2024 Jun; 103(24):e38554. PubMed ID: 38875415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria.
    Farimani M; Nazari A; Mohammadi S; Anvari Aliabad R
    Reprod Biol Endocrinol; 2021 Sep; 19(1):137. PubMed ID: 34496887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case Series on Natural Conceptions Resulting in Ongoing Pregnancies in Menopausal and Prematurely Menopausal Women Following Platelet-Rich Plasma Treatment.
    Pantos K; Simopoulou M; Pantou A; Rapani A; Tsioulou P; Nitsos N; Syrkos S; Pappas A; Koutsilieris M; Sfakianoudis K
    Cell Transplant; 2019; 28(9-10):1333-1340. PubMed ID: 31271054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Intra-uterine Injection of Platelet-rich Plasma (PRP) for Endometrial Receptivity and Thickness: a Literature Review of the Mechanisms of Action.
    Mouanness M; Ali-Bynom S; Jackman J; Seckin S; Merhi Z
    Reprod Sci; 2021 Jun; 28(6):1659-1670. PubMed ID: 33886116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case Series on Platelet-Rich Plasma Revolutionary Management of Poor Responder Patients.
    Sfakianoudis K; Simopoulou M; Nitsos N; Rapani A; Pantou A; Vaxevanoglou T; Kokkali G; Koutsilieris M; Pantos K
    Gynecol Obstet Invest; 2019; 84(1):99-106. PubMed ID: 30134239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.